Macroaneurysms and their photocoagulation in other diseases
Language
EN
Article de revue
This item was published in
Acta Ophthalmologica. 2018-12, vol. 96, p. 32-32
English Abstract
The control of the duration of macular edema is a key‐factor to prevent irreversible neuro‐retinal lesions. Pharmacological studies have demonstrated the interest of early intravitreal treatments (either anti‐VEGF or ...Read more >
The control of the duration of macular edema is a key‐factor to prevent irreversible neuro‐retinal lesions. Pharmacological studies have demonstrated the interest of early intravitreal treatments (either anti‐VEGF or dexamethasone) to control vascular macular edema, especially in retinal vein occlusions. However, in some cases, pharmacological therapy fails to control retinal exudation, either at once or after a while. The remodeling of the retinal capillary network secondary to chronic vascular disturbances can indeed maintain the exudation. Capillary macro‐aneurysm (CMA) is one of the modifications of the vascular network that can be involved in persistent or recurrent vascular edema. CMAs may be identified on the fundus as dark‐reddish round lesions often with white borders. CMA may be either isolated or gathered in clusters. In some cases, however, CMA remains barely visible. ICG‐angiography remains the most efficient imaging mode for CMA detection, enabling to precise the number of CMA(s) and their location towards the fovea. Our presentation will focus on clinical presentations of such CMAs in vascular diseases outside diabetes: retinal vein occlusions, Coats’ disease… Both management and outcomes will be discussed.Read less <
English Keywords
LEHA